Genmab
GMAB
$33.68
Share price
-2.38%
Change (1 day)
-32.64%
Change (1 year)
Categories
Market capitalization of Genmab (GMAB)
Market cap: NZ$21.48 Billion
As of March 2025 Genmab has a market cap of NZ$21.48 Billion. This makes Genmab the world's 1432th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Genmab from 2010 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$21.48 B | -9.74% |
| 2024 | NZ$23.80 B | -27.62% |
| 2023 | NZ$32.88 B | -25.3% |
| 2022 | NZ$44.02 B | 14.85% |
| 2021 | NZ$38.33 B | 3.67% |
| 2020 | NZ$36.98 B | 72.75% |
| 2019 | NZ$21.40 B | 43.2% |
| 2018 | NZ$14.94 B | 5.32% |
| 2017 | NZ$14.19 B | -2.01% |
| 2016 | NZ$14.48 B | 23.91% |
| 2015 | NZ$11.68 B | 173.31% |
| 2014 | NZ$4.27 B | 73.07% |
| 2013 | NZ$2.47 B | 193.06% |
| 2012 | NZ$0.84 B | 124.09% |
| 2011 | NZ$0.37 B | -52.11% |
| 2010 | NZ$0.78 B |
End of Day market cap according to different sources
On Mar 23rd, 2025 the market cap of Genmab was reported to be:
